VOR
Vor Biopharma Inc.
$18.04
+$1.94 (+12.05%)Today
Key Statistics
Market cap977.51M
Price-Earnings ratio-4.82
Dividend yield—
Average volume1.9M
High today$19.11
Low today$15.85
Open price$16.10
Volume1.81M
52 Week high$65.80
52 Week low$6.50
Vor Biopharma Inc.
Vor Biopharma Inc., a clinical-stage biopharmaceutical company, focuses on the development of a novel therapy in the treatment of autoimmune diseases. The company offers telitacicept, a novel fusion protein for the treatment of generalized myasthenia gravis, systemic lupus erythematosus, and rheumatoid arthritis, as well as Sjögren's disease and IgA nephrapathy. It has a license agreement with RemeGen Co., Ltd. for the exploitation, development, and commercialization of telitacicpet and related products. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.